Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05288101
Other study ID # UAQ-ISSSTE-INCMNSZ-4423632676
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2017
Est. completion date June 30, 2017

Study information

Verified date March 2022
Source Universidad Autonoma de Queretaro
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this study was to assess the effect of oral nutritional supplementation (ONS) combined with bioelectrical vector analysis (BIVA) on the nutritional and hydration status and the quality of life (QoL) in hemodialysis (HD) patients. Design and Methods: Thirty-two chronic HD patients were included in a 6-month randomized pilot study. Patients in SUPL group received a simultaneous intervention consisting of a personalized diet, 245 mL/d ONS and dry weight adjustment through BIVA. Patients in CON group received a personalized diet and dry weight adjustment by BIVA. Anthropometrical, biochemical, dietary, QoL, handgrip strength (HGS) and bioimpedance measurements were performed. Malnutrition Inflammation Score (MIS) was applied.


Description:

This was a randomized, controlled, pilot study. Due to the type of study, no sample size was calculated because the aim was to include all patients available . Patients were randomly assigned to one of two treatments: 1) simultaneous intervention of dry weight adjustment through BIVA, a personalized diet, and 245 mL/d of ONS (SUPL), or 2) dry weight adjustment by BIVA and a personalized diet (CON). Both treatments were given for six months All measurements were made in accordance with good clinical practice and the recommendations of the Helsinki Declaration on human studies. The protocol was registered and approved by the Ethics Committee of the Faculty of Natural Science of the Autonomous University of Queretaro (No. 252FCN2016) and by the Ethics Committee of the ISSSTE in Queretaro. All patients provided written informed consent to participate in this study. The supplement was provided five days per week. Three days a week, the supplement was given at the beginning of the HD session and the patients were instructed to consume it slowly during the next 3 hours. The remaining two days, the supplement was consumed at home and instructed to be consumed between meals. The ONS consisted of one can of polymeric formula (Enterex DBT, Victus Laboratories) and 5.6 g of a protein powder supplement (Proteinex, Victus Laboratories). The final mixture provided 240 kcal, 17 g protein, 8.1 g lipids, 25 g carbohydrates, 4 g dietary fiber, 201 mg sodium, 490 mg calcium, 356 mg phosphorus and 371 mg potassium. When the ONS was provided at the HD unit, the mixture was prepared at the hospital´s enteral mixing center and delivered to the patient in a plastic cup with lid and a straw. For the two remaining days, the patients were instructed about the mixture preparation and they were given two cans of supplement and two sealed plastic bags with 5.6 grams of protein powder each one. Adherence to supplement intake was determined by recording the number of servings consumed weekly. For this purpose, at the end of each HD session, the plastic cups were collected to ensure the total consumption of the supplement and for the ONS consumed at home, the patients were asked to return empty cans and plastic bags to the research staff. Both groups received the intervention to adjust dry weight in order to reach normohydration. Those participants with post-dialysis vectors located within the 50 or 75% ellipses, were considered to be in dry weight, so they did not require any fluid removal adjustment. However, participants with vectors outside the 75% ellipse were considered overhydrated or dehydrated and dry weight was adjusted. In these patients, if the vectors fell outside the 75% ellipse but within the 95%, above or below the major axis, the established dry weight was adjusted by 0.5 Kg. If the vectors fell outside the 95% ellipse, the weight was adjusted by 1.0 Kg. Patients in both groups also received a personalized diet according to the recommendations of the KDOQI guidelines and the European best practice guidelines on nutrition: 35 Kcal /ideal body weight/day, 1.2 g protein/ideal body weight/day, Na <2000 mg/day, potassium <2000 mg/day, and P <1000 mg/day. Diets were planned and designed by trained renal dietitians and were given to the patients at the beginning of the study. To specify the adequate portion size, food models and photographs of utensils were used. Evaluation of food intake was performed monthly by a three-day food record in order to assess adherence.


Recruitment information / eligibility

Status Completed
Enrollment 39
Est. completion date June 30, 2017
Est. primary completion date June 30, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients on chronic HD undergoing thrice weekly hemodialysis (at least three hours per treatment) for more than three months were included. Exclusion Criteria: - Patients with amputations of any limb, metal implants, diagnosis of dementia, or current consumption of nutritional supplements were excluded.

Study Design


Intervention

Dietary Supplement:
Proteinex and Enterex DBT Victus Laboratories
The supplement was provided five days per week. Three days a week, the supplement was given at the beginning of the HD session and the patients were instructed to consume it slowly during the next 3 hours. The remaining two days, the supplement was consumed at home and instructed to be consumed between meals. The ONS consisted of one can of polymeric formula (Enterex DBT, Victus Laboratories) and 5.6 g of a protein powder supplement (Proteinex, Victus Laboratories). The final mixture provided 240 kcal, 17 g protein, 8.1 g lipids, 25 g carbohydrates, 4 g dietary fiber, 201 mg sodium, 490 mg calcium, 356 mg phosphorus and 371 mg potassium
Procedure:
Dry weight adjustment through BIVA
Those participants with post-dialysis vectors located within the 50 or 75% ellipses, were considered to be in dry weight, so they did not require any fluid removal adjustment. However, participants with vectors outside the 75% ellipse were considered overhydrated or dehydrated and dry weight was adjusted. In these patients, if the vectors fell outside the 75% ellipse but within the 95%, above or below the major axis, the established dry weight was adjusted by 0.5 Kg. If the vectors fell outside the 95% ellipse, the weight was adjusted by 1.0 Kg.

Locations

Country Name City State
Mexico HD unit of the Social Security Institute for Government Employees (ISSSTE as per initials in Spanish Queretaro

Sponsors (4)

Lead Sponsor Collaborator
Universidad Autonoma de Queretaro Ball State University, Indiana University School of Medicine, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Country where clinical trial is conducted

Mexico, 

References & Publications (8)

Atilano-Carsi X, Miguel JL, Martínez Ara J, Sánchez Villanueva R, González García E, Selgas Gutiérrez R. [Bioimpedance vector analysis as a tool for the determination and adjustment of dry weight in patients undergoing hemodialysis]. Nutr Hosp. 2015 May 1 — View Citation

Carrero JJ, Thomas F, Nagy K, Arogundade F, Avesani CM, Chan M, Chmielewski M, Cordeiro AC, Espinosa-Cuevas A, Fiaccadori E, Guebre-Egziabher F, Hand RK, Hung AM, Ikizler TA, Johansson LR, Kalantar-Zadeh K, Karupaiah T, Lindholm B, Marckmann P, Mafra D, P — View Citation

Hanna RM, Ghobry L, Wassef O, Rhee CM, Kalantar-Zadeh K. A Practical Approach to Nutrition, Protein-Energy Wasting, Sarcopenia, and Cachexia in Patients with Chronic Kidney Disease. Blood Purif. 2020;49(1-2):202-211. doi: 10.1159/000504240. Epub 2019 Dec — View Citation

Ikizler TA, Cano NJ, Franch H, Fouque D, Himmelfarb J, Kalantar-Zadeh K, Kuhlmann MK, Stenvinkel P, TerWee P, Teta D, Wang AY, Wanner C; International Society of Renal Nutrition and Metabolism. Prevention and treatment of protein energy wasting in chronic — View Citation

Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis. 2003 Nov;42(5):864-81. Review. — View Citation

Nieves-Anaya I, Várgas MB, Mayorga H, García OP, Colín-Ramírez E, Atilano-Carsi X. Comparison of nutritional and hydration status in patients undergoing twice and thrice-weekly hemodialysis: a silent drama in developing countries. Int Urol Nephrol. 2021 Mar;53(3):571-581. doi: 10.1007/s11255-020-02697-3. Epub 2021 Jan 4. — View Citation

Pupim LB, Majchrzak KM, Flakoll PJ, Ikizler TA. Intradialytic oral nutrition improves protein homeostasis in chronic hemodialysis patients with deranged nutritional status. J Am Soc Nephrol. 2006 Nov;17(11):3149-57. Epub 2006 Oct 4. — View Citation

Sabatino A, Regolisti G, Karupaiah T, Sahathevan S, Sadu Singh BK, Khor BH, Salhab N, Karavetian M, Cupisti A, Fiaccadori E. Protein-energy wasting and nutritional supplementation in patients with end-stage renal disease on hemodialysis. Clin Nutr. 2017 J — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in nutritional status from baseline to 6 months Nutritional status was assessed by the Malnutrition Inflammation Score (MIS). MIS is a 27 points maximum scale. According to the total score obtained, the following diagnoses were considered: normal nutritional status (0 points), mild undernutrition (1 - 9 points), moderate undernutrition (10 - 19 points) and severe undernutrition (> 20 points) At the beginning of the study (baseline) and at the end of the intervention (six months after starting the intervention).
Primary Change in hydration status from baseline to 6 months Hydration status was evaluated by bioelectrical impedance vector analysis (BIVA). BIA was measured immediately before the start and ten minutes after the end of the mid-week HD session, by the same trained personnel. Individual resistance and reactance values were standardized by the height of each patient (R/H, Xc/H) and then plotted on the reference ellipses of the Mexican population.
Dehydration was considered when the vector was at the top, outside the 75% ellipses Overhydration was considered when the vector was at the bottom, outside the 75% ellipses Normohydration was considered when the vector was within the ellipses of 50 and 75%
Every week through study completion (six months).
Secondary Change in Quality of life evaluation (KDQOL SF) from baseline to 6 months QoL was assessed using the Kidney Disease Quality of Life-Short Form (KDQOL-SF). The instrument includes 36 items. Responses were scored from 0 to 100 points, <50 points meant poor QoL. The higher the score (>50 points), the better QoL. At the beginning of the study (baseline) and at the end of the intervention (six months after starting the intervention).
Secondary Change in hand grip strength (HGS) from baseline to 6 months HGS was measured with a dynamometer on the non-fistula side after the HD session, three consecutive times, with a rest period of 1 minute between measurements and the highest value was recorded. Poor strength of the hand and forearm muscles were considered with <20 Kg and <30 Kg for women and men, respectively. At the beginning of the study (baseline) and at the end of the intervention (six months after starting the intervention)
Secondary Monthly change in gastrointestinal symptoms evaluation (GSQ) from baseline to 6 months Gastrointestinal symptoms were assessed with the self-administered GI symptoms questionnaire (GSQ). The GSQ includes 8 items: anorexia, nausea, vomiting, heartburn, bloating, abdominal pain, constipation and diarrhea. Each symptom is rated between 1 to 5 points, and the higher the score, the more severe the symptoms Every month through study completion (six months).
Secondary Monthly change in calorie intake from baseline to 6 months Calorie intake was evaluated by a three-day food record. Patients were asked to record all foods consumed during three days in the same week (one dialysis day, one non-dialysis day, and one weekend day).Three-day food records were analyzed using a nutrient software program and reported as calories consumed per kilogram of weight Every month through study completion (six months).
Secondary Monthly change in protein intake from baseline to 6 months Protein intake was evaluated by a three-day food record. Patients were asked to record all foods consumed during three days in the same week (one dialysis day, one non-dialysis day, and one weekend day).Three-day food records were analyzed using a nutrient software program and reported as grams of protein consumed per kilogram of weight Every month through study completion (six months).
Secondary Change in postdialysis weight from baseline to 6 months Body weight was measured before and after all hemodialysis sessions during the six months of the intervention and reported in kilograms, according to the International Society for the Advancement of Kinanthropometry (ISAK) guidelines. Three times a week in every hemodialysis session through study completion (six months).
Secondary Change in postdialysis body mass index from baseline to 6 months Body mass index was calculated by dividing weight by height squared and reported as kilogram/meters2. Every month through study completion (six months).
Secondary Change in arm muscle circumference from baseline to 6 months Arm circumference and triceps skinfold (TSF) were measured at the end of the mid-week HD session according to the International Society for the Advancement of Kinanthropometry (ISAK) guidelines in triplicate by the same standardized dietitian.
Arm circumference was calculated usig the following formula: arm circumference (mm) - (3.1416 x triceps skinfold (mm)) and reported in mm
At the beginning of the study (baseline) and at the end of the intervention (six months after starting the intervention)
Secondary Change in fasting glucose from baseline to 6 months Fasting blood samples were drawn from the vascular access of each participant before the start of the HD session. All tests were performed at the hospital´s clinical laboratory using certified methods.
Fasting glucose was determined by electric impedance and fluorescence and reported in mg/dl
At the beginning of the study (baseline) and at the end of the intervention (six months after starting the intervention)
Secondary Change in fasting urea from baseline to 6 months Fasting blood samples were drawn from the vascular access of each participant before the start of the HD session. All tests were performed at the hospital´s clinical laboratory using certified methods.
Fasting urea was determined by electric impedance and fluorescence and reported in mg/dl
At the beginning of the study (baseline) and at the end of the intervention (six months after starting the intervention)
Secondary Change in fasting creatinine from baseline to 6 months Fasting blood samples were drawn from the vascular access of each participant before the start of the HD session. All tests were performed at the hospital´s clinical laboratory using certified methods.
Fasting creatinine was determined by electric impedance and fluorescence and reported in mg/dl
At the beginning of the study (baseline) and at the end of the intervention (six months after starting the intervention)
Secondary Change in fasting phosphorus from baseline to 6 months Fasting blood samples were drawn from the vascular access of each participant before the start of the HD session. All tests were performed at the hospital´s clinical laboratory using certified methods.
Fasting phosphorus was determined by electric impedance and fluorescence and reported in mg/dl
At the beginning of the study (baseline) and at the end of the intervention (six months after starting the intervention)
Secondary Change in fasting sodium from baseline to 6 months Fasting blood samples were drawn from the vascular access of each participant before the start of the HD session. All tests were performed at the hospital´s clinical laboratory using certified methods.
Fasting sodium was determined by electric impedance and fluorescence and reported in mEq/L
At the beginning of the study (baseline) and at the end of the intervention (six months after starting the intervention)
Secondary Change in fasting potassium from baseline to 6 months Fasting blood samples were drawn from the vascular access of each participant before the start of the HD session. All tests were performed at the hospital´s clinical laboratory using certified methods.
Fasting potassium was determined by electric impedance and fluorescence and reported in mEq/L
At the beginning of the study (baseline) and at the end of the intervention (six months after starting the intervention)
Secondary Change in fasting calcium from baseline to 6 months Fasting blood samples were drawn from the vascular access of each participant before the start of the HD session. All tests were performed at the hospital´s clinical laboratory using certified methods.
Fasting calcium was determined by electric impedance and fluorescence and reported in mg/dL
At the beginning of the study (baseline) and at the end of the intervention (six months after starting the intervention)
Secondary Change in fasting albumin from baseline to 6 months Fasting blood samples were drawn from the vascular access of each participant before the start of the HD session. All tests were performed at the hospital´s clinical laboratory using certified methods.
Fasting albumin was determined by electric impedance and fluorescence and reported in g/dL
At the beginning of the study (baseline) and at the end of the intervention (six months after starting the intervention)
Secondary Change in fasting transferrin from baseline to 6 months Fasting blood samples were drawn from the vascular access of each participant before the start of the HD session. All tests were performed at the hospital´s clinical laboratory using certified methods.
Fasting transferrin was determined by chemiluminescence and reported in mg/dL
At the beginning of the study (baseline) and at the end of the intervention (six months after starting the intervention)
Secondary Change in fasting high-sensitivity C reactive protein from baseline to 6 months Fasting blood samples were drawn from the vascular access of each participant before the start of the HD session. All tests were performed at the hospital´s clinical laboratory using certified methods.
Fasting high-sensitivity C reactive protein was determined by plate agglutination and reported in mg/dL
At the beginning of the study (baseline) and at the end of the intervention (six months after starting the intervention)
See also
  Status Clinical Trial Phase
Recruiting NCT06084715 - The INSTITUT Study
Recruiting NCT05608707 - APPETITE: Plant Protein and Exercise Solutions for the Prevention of Undernutrition in Older Adults. N/A
Completed NCT01977950 - Nutritional Risk and Nutritional Care Practices in the Hospitalized Elderly N/A
Completed NCT01197768 - A Multi-Component Behavioral Nutrition Intervention for Homebound Elderly N/A
Active, not recruiting NCT02463565 - Assessment of Food Intake in Hospitalized Patients N/A
Completed NCT05517395 - The Effectiveness of HBM-based Education Program on Improve Knowledge and Behaviors N/A
Recruiting NCT05473312 - Women Supporting Women to Improve Infant and Child Feeding Practices N/A
Recruiting NCT05094024 - Shelf-Stable MDCF-2 for Children With Undernutrition N/A
Completed NCT04105621 - Westlake Personalized Nutrition and Health Cohort for Drug Addicts
Completed NCT02213393 - Cater With Care Effect Study N/A
Completed NCT02141256 - Can Protein Intake be Increased by Offering Protein-enriched Foods and Drinks? N/A
Active, not recruiting NCT03450174 - Effectiveness of Multiple Micro-nutrient Fortified Fudge on Nutritional Status of 3-5 Years of Age Children N/A
Completed NCT05574842 - The Effect of Double Duty Interventions on Double Burden of Malnutrition Among School Adolescents in Ethiopia N/A
Recruiting NCT05952479 - The Comparison of Handgrip Strength, Lean Mass, and Blood Pressure in Primary School Children Aged 8-10 Years Old With Undernutrition and Normal Nutritional Status
Completed NCT04640389 - Rural-urban Disparities in the Nutritional Status of Younger Adolescents in Tanzania.
Completed NCT03378141 - Maternal Nutrition Interventions in Uttar Pradesh, India N/A
Completed NCT03211845 - Feasibility of Nutritional Telemonitoring in Elderly Home Care Patients N/A
Completed NCT02476110 - The ONSHUG Survey : A Quality Care Programme N/A
Completed NCT02656186 - Supplementation With Nutrients Modulating IGF-1 and Cytokines in Elderly People at Risk of Undernutrition Phase 3
Completed NCT02496247 - Canned Herring for Prevention of Childhood Malnutrition During the Early Rainy Season in Rural Guinea-Bissau N/A